Back to top
more

Applied DNA Sciences (APDN)

(Delayed Data from NSDQ)

$4.27 USD

4.27
187,114

+0.04 (0.95%)

Updated Aug 8, 2025 03:58 PM ET

After-Market: $4.24 -0.03 (-0.70%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (60 out of 244)

Industry: Security and Safety Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -75% and 33%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 3.03% and 1.63%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Intellicheck Mobilisa, Inc. (IDN) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Intellicheck Mobilisa (IDN) delivered earnings and revenue surprises of -100% and 3.98%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

GrafTech International (EAF) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

GrafTech (EAF) delivered earnings and revenue surprises of 7.14% and 1.96%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Resideo Technologies (REZI) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

Resideo Technologies (REZI) delivered earnings and revenue surprises of 1.75% and 0.69%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions

by Zacks Equity Research

Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions have been highlighted in this Investment Ideas article.

Andrew Rocco headshot

WHO Declares Monkeypox Public Emergency: 5 Mpox Stocks to Watch

by Andrew Rocco

Is the next pandemic here. With health officials declaring Monkeypox a public health emergency, investors need to be watching Monkeypox-related stocks.

Zacks Equity Research

Applied DNA Sciences (APDN) Tops Q3 Earnings Estimates

by Zacks Equity Research

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 173.44% and 16%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Axon Enterprise (AXON) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Axon (AXON) delivered earnings and revenue surprises of 13.21% and 5.70%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Ball (BALL) Q2 Earnings Beat Estimates

by Zacks Equity Research

Ball (BALL) delivered earnings and revenue surprises of 1.37% and 3.52%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Applied DNA Sciences (APDN) Upgraded to Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Applied DNA Sciences (APDN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Sanghamitra Saha headshot

Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E

by Sanghamitra Saha

Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include CLEAR Secure (YOU), Applied DNA Sciences (APDN), Phreesia (PHR), Vigil Neuroscience (VIGL) and Biodesix (BDSX).

Sanghamitra Saha headshot

Time to Play 5 Top-Ranked Stocks With Rising P/E?

by Sanghamitra Saha

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include AMC Entertainment (AMC), Exagen (XGN), Health Catalyst (HCAT), CLEAR Secure (YOU) and Applied DNA Sciences (APDN).

Zacks Equity Research

Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -15.43% and 3.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Clear Secure (YOU) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Clear Secure (YOU) delivered earnings and revenue surprises of 64.71% and 3.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Rockwell Automation (ROK) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Rockwell Automation (ROK) delivered earnings and revenue surprises of 16.28% and 4.22%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Allegion (ALLE) Q1 Earnings Surpass Estimates

by Zacks Equity Research

Allegion (ALLE) delivered earnings and revenue surprises of 9.93% and 2.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is Applied DNA Sciences (APDN) Outperforming Other Industrial Products Stocks This Year?

by Zacks Equity Research

Here is how Applied DNA Sciences (APDN) and Encore Wire (WIRE) have performed compared to their sector so far this year.

Zacks Equity Research

Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 70.97% and 27.29%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

ADT (ADT) Q2 Earnings and Revenues Miss Estimates

by Zacks Equity Research

ADT (ADT) delivered earnings and revenue surprises of -30.43% and 2.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Proto Labs (PRLB) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Proto Labs (PRLB) delivered earnings and revenue surprises of 10% and 0.12%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Kennametal (KMT) Q4 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Kennametal (KMT) delivered earnings and revenue surprises of -16.39% and 2.86%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Alarm.com Holdings (ALRM) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Alarm.com (ALRM) delivered earnings and revenue surprises of 36.67% and 1.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Clear Secure (YOU) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Clear Secure (YOU) delivered earnings and revenue surprises of 300% and 2.03%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Napco (NSSC) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Napco (NSSC) delivered earnings and revenue surprises of 52.63% and 3.25%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?